• 1. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 2. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 5. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Chloroquinolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines Chloroquinolines

Introduction to (2,5-dichloro-8-methylquinolin-3-yl)methanol (CAS No. 1017429-51-4)

Compound (2,5-dichloro-8-methylquinolin-3-yl)methanol, identified by its CAS number 1017429-51-4, is a significant molecule in the realm of pharmaceutical chemistry and medicinal research. This heterocyclic compound features a quinoline backbone, which is a well-documented scaffold in the development of bioactive molecules. The presence of chloro and methyl substituents at specific positions on the quinoline ring enhances its pharmacological potential, making it a subject of extensive interest in drug discovery programs.

The structural attributes of (2,5-dichloro-8-methylquinolin-3-yl)methanol contribute to its unique chemical properties and biological activities. The quinoline moiety is renowned for its role in various therapeutic applications, particularly in antimalarial and anticancer agents. The introduction of chlorine atoms at the 2 and 5 positions increases the electron-withdrawing effect, which can modulate the reactivity and binding affinity of the molecule. Similarly, the methyl group at the 8 position influences the overall electronic distribution and steric environment, further tailoring its interaction with biological targets.

In recent years, there has been a surge in research focusing on quinoline derivatives due to their broad spectrum of biological activities. Studies have demonstrated that compounds incorporating the quinoline scaffold exhibit potent effects against various pathogens and diseases. Specifically, derivatives like (2,5-dichloro-8-methylquinolin-3-yl)methanol have shown promise in inhibiting enzymes and receptors involved in cancer progression and infectious diseases. The methanol moiety at the 3-position provides a hydroxyl group that can participate in hydrogen bonding interactions, enhancing binding to biological targets.

One of the most compelling aspects of (2,5-dichloro-8-methylquinolin-3-yl)methanol is its potential as a lead compound for drug development. Researchers have leveraged computational methods and high-throughput screening to identify derivatives with improved pharmacokinetic profiles and reduced toxicity. The structural features of this compound make it an attractive candidate for further optimization through structure-based drug design approaches. By modifying substituents or exploring analogs, scientists aim to enhance its efficacy while minimizing side effects.

The synthesis of (2,5-dichloro-8-methylquinolin-3-yl)methanol involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies have been employed to achieve high yields and purity levels. Techniques such as palladium-catalyzed cross-coupling reactions and directed ortho-metalation have been particularly useful in constructing the complex quinoline core. These synthetic strategies not only facilitate the preparation of this compound but also provide insights into developing other related molecules.

Recent studies have highlighted the importance of quinoline derivatives in addressing emerging health challenges. For instance, compounds with similar structures to (2,5-dichloro-8-methylquinolin-3-yl)methanol have been investigated for their antiviral properties. The ability of these molecules to interfere with viral replication mechanisms makes them valuable candidates for developing treatments against RNA viruses. Additionally, their potential role in modulating inflammatory pathways has sparked interest in exploring their therapeutic applications beyond infectious diseases.

The pharmacological profile of (2,5-dichloro-8-methylquinolin-3-yl)methanol is further illuminated by preclinical studies that have evaluated its interactions with various biological targets. These studies have revealed that the compound exhibits selective binding to enzymes such as kinases and phosphodiesterases, which are crucial for cellular signaling pathways involved in cancer and inflammation. By understanding these interactions at a molecular level, researchers can design more targeted therapies that leverage the unique properties of this compound.

In conclusion, (2,5-dichloro-8-methylquinolin-3-yl)methanol (CAS No. 1017429-51-4) represents a promising entity in pharmaceutical research due to its structural complexity and biological potential. Its quinoline core combined with strategic substituents positions it as a valuable scaffold for developing novel therapeutic agents. As research continues to uncover new applications for this compound and its derivatives, it is likely to play an increasingly important role in addressing global health challenges through innovative drug discovery efforts.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)